Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-09

FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved a supplemental application for Imitrex (sumatriptan) submitted by GlaxoSmithKline LLC. This approval updates the product's labeling per the sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imitrex (Sumatriptan)

Snippet

SUPPL AP for IMITREX (SUMATRIPTAN)